US Patent

US9216176 — Abuse resistant drug formulation

Formulation · Assigned to Cima Labs Inc · Expires 2027-09-13 · 1y remaining

Vulnerability score 38/100 Strong — defensible against typical IPR challenges

What this patent protects

This patent protects an abuse-resistant drug formulation that includes coated particles with improved controlled release and/or crush resistance.

USPTO Abstract

A pharmaceutical composition may include a coated particulate which may include at least one active pharmaceutical ingredient, particularly one susceptible to abuse by an individual. The coated particles may include a fat/wax and have improved controlled release and/or crush resistance. Method of making these coated particulate and dosage forms therewith are also described.

Drugs covered by this patent

hydrocodone-bitartrate (HYDROCODONE BITARTRATE)

Patent Metadata

Patent number: US9216176
Jurisdiction: US
Classification: Formulation
Expires: 2027-09-13
Drug substance claim: No
Drug product claim: Yes
Assignee: Cima Labs Inc
Source: FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.